Skip to main content

Advertisement

SpringerLink
Log in

Epidemiology of neuroimmunological diseases

  • Published:
Journal of Neurology Aims and scope Submit manuscript

An Erratum to this article was published on 01 February 2008

Abstract

This review gives an overview of various neuroimmunological diseases in terms of incidence and prevalence rates, age and sex distribution, and the frequency of subtypes, if applicable. The disorders selected for review are inflammatory muscle disorders (polymyositis, dermatomyositis and inclusion body myositis), myasthenia gravis, immune-mediated polyneuropathies (Guillain-Barré syndrome, chronic polyneuritis and vasculitic neuropathies), and multiple sclerosis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Aragones JM, Bolibar I, Bonfill X, Bufill E, Mummany A, Alonso F, Illa I (2003) Myasthenia gravis: a higher than expected incidence in the elderly. Neurology 60(6):1024–1026

    PubMed  CAS  Google Scholar 

  2. Arnason BG, Soliven B (1993) Acute inflammatory demyelinating polyradiculoneuropathy. In: Dyck PJ, Thomas PK, Griffin JW, Low PA, Poduslo JF (eds) Peripheral neuropathy. WB, Saunders, Philadelphia, pp 1437–1497

  3. Badrising UA, Maat-Schiemann M, van Duinen SG et al. (2000) Epidemiology of inclusion body myositis in the Netherlands: a nationwide study. Neurology 55:1385–1387

    PubMed  CAS  Google Scholar 

  4. Busby M, Donaghy M (2003) Chronic dysimmune neuropathy. A subclassification based upon the clinical features of 102 patients. J Neurol 250:714–724

    Article  PubMed  Google Scholar 

  5. Cheng Q, Jiang GX, Fredrikson S (2000) Incidence of Guillain-Barré syndrome in Sweden 1996. Eur J Neurol 7:11–16

    Article  PubMed  CAS  Google Scholar 

  6. Collins MP, Periquet MI (2004) Non-systemic vasculitic neuropathy. Curr Opin Neurol 17:587–598

    Article  PubMed  CAS  Google Scholar 

  7. Compston A, Coles A (2002) Multiple sclerosis. Lancet 359:1221–1231

    Article  PubMed  Google Scholar 

  8. Dalakas MC (2004) Inflammatory disorders of muscle: progress in polymyositis, dermatomyositis and inclusion body myositis. Curr Opin Neurol 17:561–567

    Article  PubMed  CAS  Google Scholar 

  9. Dalakas MC, Hohlfeld R (2003) Polymyositis and dermatomyositis. Lancet 362:971–982

    Article  PubMed  CAS  Google Scholar 

  10. Drachman DB (1994) Myasthenia gravis. N Engl J Med 330:1797–1810

    Article  PubMed  CAS  Google Scholar 

  11. Dyck PJ, Benstead TJ, Conn DL et al. (1987) Nonsystemic vasculitic neuropathy. Brain 110:843–853

    PubMed  Google Scholar 

  12. Emilia-Romagna Study Group on Clinical and Epidemiological Problems in Neurology (1997) A prospective study on the incidence and prognosis of Guillain-Barré syndrome in Emilia-Romagna region, Italy (1992–1993). Neurology 48:214–221

    Google Scholar 

  13. Flachenecker P, Zettl UK (2005) Epidemiologie. In: Schmidt RM, Hoffmann F (eds) Multiple Sklerose. Urban and Fischer, München, pp 9–15

  14. Flachenecker P, Zettl UK, Götze U, Haas J, Schimrigk S, Elias W, Pette M, Eulitz M, Hennig M, Bertram J, Hollweck R, Neiss A, Daumer M, Pitschnau-Michel D, Rieckmann P (2005) MS-Register in Deutschland—Design und erste Ergebnisse der Pilotphase. Nervenarzt 76:967–975

    Article  PubMed  CAS  Google Scholar 

  15. Govoni V, Granieri E (2001) Epidemiology of the Guillain-Barre syndrome. Curr Opin Neurol 14:605–613

    Article  PubMed  CAS  Google Scholar 

  16. Haber P, DeStefano F, Angulo FJ, Iskander J, Shadomy SV, Weintraub E, Chen RT (2004) Guillain-Barre syndrome following influenza vaccination. JAMA 292:2478–2481

    Article  PubMed  CAS  Google Scholar 

  17. Hartung HP, Kieseier BC, Kiefer R (2001) Progress in Guillain-Barré syndrome. Curr Opin Neurol 14:597–604

    Article  PubMed  CAS  Google Scholar 

  18. Hartung HP, Pollard JD, Harvey GK, Toyka KV (1995) Immunopathogenesis and treatment of the Guillain-Barré syndrome—Part I Muscle Nerve 18:137–153

    Article  PubMed  CAS  Google Scholar 

  19. Hein T, Hopfenmüller W (2000) Hochrechnung der Zahl an Multiple Sklerose erkrankten Patienten in Deutschland. Nervenarzt 71:288–294

    Article  PubMed  CAS  Google Scholar 

  20. Hohlfeld R, Wekerle H (1994) The thymus in myasthenia gravis. Neurol Clin 12:331–342

    PubMed  CAS  Google Scholar 

  21. Hovi T, Stenvik M (2000) Surveillance of patients with acute flaccid paralysis in Finland: report of a pilot study. Bull World Health Organ 78:298–304

    PubMed  CAS  Google Scholar 

  22. Hunder GG, Arend WP, Bloch DA et al. (1990) The American College of Rheumatology 1990 criteria for the classification of vasculitis. Introduction. Arthritis Rheum 33:1065–1067

    Article  PubMed  CAS  Google Scholar 

  23. Jennette JC, Falk RJ,Andrassy K et al. (1994) Nomenclature of systemic vasculitides. Proposal of an international consensus conference. Arthritis Rheum 37:187–192

    PubMed  CAS  Google Scholar 

  24. Jiang GX, Cheng Q, Link H, de Pedro-Cuesta J (1997) Epidemiological features of Guillain-Barré syndrome in Sweden, 1978–1993. J Neurol Neurosurg Psychiatry 62:447–453

    PubMed  CAS  Google Scholar 

  25. Kaida K, Kusunoki S, Kamakura K et al. (2000) Guillain-Barré syndrome with antibody to a ganglioside, Nacetylgalactosaminyl GD1a. Brain 123:116–124

    Article  PubMed  Google Scholar 

  26. Keegan BM, Noseworthy JH (2002) Multiple sclerosis. Annu Rev Med 53:285–302

    Article  PubMed  CAS  Google Scholar 

  27. Kissel JT (2001) Vasculitic neuropathies. In: Gilman S (ed) MedLink Neurology. MedLink Corporation, San Diego

  28. Kurtzke JF (1993) Epidemiologic evidence for multiple sclerosis as an infection. Clin Microbiol Rev 6:382–427

    PubMed  CAS  Google Scholar 

  29. Lasky T, Terracciano GJ, Magder L, Koski CL, Ballesteros M, Nash D, Clark S, Haber P, Stolley PD, Schonberger LB, Chen RT (1998) The Guillain-Barre syndrome and the 1992–1993 and 1993–1994 influenza vaccines. N Engl J Med 339:1797–1802

    Article  PubMed  CAS  Google Scholar 

  30. Léger JM, Behin A (2005) Multifocal motor neuropathy. Curr Opin Neurol 18:567–573

    PubMed  Google Scholar 

  31. Lublin FD, Reingold SC (1996) Defining the clinical course of multiple sclerosis: results of an international survey. National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis. Neurology 46:907–911

    PubMed  CAS  Google Scholar 

  32. Mantegazza R, Baggi F, Antozzi C, Confalonieri P, Morandi L, Bernasconi P, Andreetta F, Simoncini O, Campanella A, Beghi E, Cornelio F (2003) Myasthenia gravis (MG): epidemiological data and prognostic factors. Ann N Y Acad Sci 998:413–423

    Article  PubMed  Google Scholar 

  33. Martyn C (1991) The epidemiology of multiple sclerosis. In: Matthews WB (ed) McAlpines’s multiple sclerosis. Churchill Livingstone, New York, pp 3–40

  34. Mayr WT, Pittock SJ, McClelland RL, Jorgensen NW, Noseworthy JH, Rodriguez M (2003) Incidence and prevalence of multiple sclerosis in Olmsted County, Minnesota, 1985–2000. Neurology 61:1373–1377

    PubMed  CAS  Google Scholar 

  35. Meyer-Rienecker H, Buddenhagen F (1988) Incidence of multiple sclerosis: a periodic or stable phenomenon. J Neurol 235:241–244

    Article  PubMed  CAS  Google Scholar 

  36. Mygland A, Monstad P (2001) Chronic polyneuropathies in Vest-Agder, Norway. Eur J Neurol 8:157–165

    Article  PubMed  CAS  Google Scholar 

  37. Nobile-Orazio E (2004) IgM paraproteinaemic neuropathies. Curr Opin Neurol 17:599–605

    Article  PubMed  CAS  Google Scholar 

  38. Oldflors A, Lindberg C (2005) Diagnosis, pathogenesis and treatment of inclusion body myositis. Curr Opin Neurol 18:497–503

    Article  Google Scholar 

  39. Olney RK, Lewis RA, Putnam TD, Campellone RV (2003) Consensus criteria for the diagnosis of multifocal motor neuropathy. Muscle Nerve 27:117–121

    Article  PubMed  Google Scholar 

  40. Palace J, Vincent A, Beeson D (2001) Myasthenia gravis: diagnostic and management dilemmas. Curr Opin Neurol 14:583–589

    Article  PubMed  CAS  Google Scholar 

  41. Phillips BA, Zilko PJ, Mastaglia FL (2000) Prevalence of sporadic inclusion body myositis in Western Australia. Muscle Nerve 23:970–972

    Article  PubMed  CAS  Google Scholar 

  42. Phillips LH (2004) The epidemiology of myasthenia gravis. Semin Neurol 24:17–20

    Article  PubMed  Google Scholar 

  43. Pinching AJ, Peters DK, Newsom Davis J (1976) Remission of myasthenia gravis following plasma exchange. Lancet 2:1373–1376

    Article  PubMed  CAS  Google Scholar 

  44. Poser CM (1994) The epidemiology of multiple sclerosis: a general overview. Ann Neurol 36(Suppl 2):S180–S193

    Article  PubMed  Google Scholar 

  45. Potagas C, Dellatolas G, Tavernarakis A, Molari H, Mourtzouhou P, Koutra H, Matikas N, Balakas N (2004) Myasthenia gravis: changes observed in a 30-years retrospective clinical study of a hospital-based population. J Neurol 251:116–117

    Article  PubMed  Google Scholar 

  46. Rees JH, Soudain SE, Gregson NA, Hughes RA (1995) Campylobacter jejuni infection and Guillain-Barré syndrome. N Engl J Med 333:1374–1379

    Article  PubMed  CAS  Google Scholar 

  47. Saperstein DS, Katz JS, Amato AA, Barohn RJ (2001) Clinical spectrum of chronic acquired demyelinating polyneuropathies. Muscle Nerve 24:311–324

    Article  PubMed  CAS  Google Scholar 

  48. Schonberger LB, Bregman DJ, Sullivan-Bolyai JZ et al. (1979) Guillain-Barré syndrome following vaccination in the national influenza immunization program, United States, 1976–1977. Am J Epidemiol 110:105

    PubMed  CAS  Google Scholar 

  49. Sommer C, Heuss D, Schlotter-Weigel B, Engelhardt A, Reinhold-Keller E (2003) Diagnostik und Therapie der vaskulitischen Neuropathien und Neuropathien bei Kollagenosen. In: Diener HC, für die Kommission „Leitlinien“ der Deutschen Gesellschaft für Neurologie (eds) Leitlinien für Diagnostik und Therapie in der Neurologie. Georg Thieme Verlag, Stuttgart New York, pp 263–273

  50. Teixeira A, Cherin P, Demoule A et al. (2005) Diaphragmatic dysfunction in patients with idiopathic inflammatory myopathies. Neuromuscul Disord 15:32–39

    Article  PubMed  Google Scholar 

  51. Toyka KV, Drachman DB, Pestronk A, Kao I (1975) Myasthenia gravis: passive transfer from man to mouse. Science 190:397–399

    PubMed  CAS  Google Scholar 

  52. van der Meulen MFG, Bonner M, Hoogendijk JE et al. (2003) Polymyositis: a diagnostic entity reconsidered. Neurology 61:316–321

    PubMed  CAS  Google Scholar 

  53. van Doorn PA, Ruts L (2004) Treatment of chronic inflammatory demyelinating polyneuropathy. Curr Opin Neurol 17:607–613

    Article  PubMed  CAS  Google Scholar 

  54. van Koningsveld R, van Doorn PA, Schmitz PIM et al. (2000) Mild forms of Guillain-Barré syndrome in an epidemiological survey in the Netherlands. Neurology 54:620–625

    PubMed  CAS  Google Scholar 

  55. Viala K, Renie T, Maisonobe T et al. (2004) Follow-up and response to treatment in 23 patients with Lewis-Sumner syndrome. Brain 127:2010–2017

    Article  PubMed  CAS  Google Scholar 

  56. Voermans NC, Vaneker M, Hengstman GJ et al. (2004) Primary respiratory failure in inclusion body myositis. Neurology 63:2191–2192

    PubMed  CAS  Google Scholar 

  57. Weinshenker BG, Bass B, Rice GP, Noseworthy JH, Carriere W, Baskerville J, Ebers GC (1989) The natural history of multiple sclerosis: a geographically based study. 1. Clinical course and disability. Brain 112:133–146

    PubMed  Google Scholar 

  58. Willison HJ, Veitch J, Paterson G, Kennedy PGE (1993) Miller Fisher syndrome is associated with serum antibodies to GQ1b ganglioside. J Neurol Neurosurg Psychiatry 56:204–206

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Neurological Rehabilitation Center „Quellenhof“, Kuranlagenallee 2, 75323, Bad Wildbad, Germany

    Peter Flachenecker MD

Authors
  1. Peter Flachenecker MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Peter Flachenecker MD.

Additional information

An erratum to this article is available at http://dx.doi.org/10.1007/s00415-008-0881-z.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Flachenecker, P. Epidemiology of neuroimmunological diseases. J Neurol 253 (Suppl 5), v2–v8 (2006). https://doi.org/10.1007/s00415-006-5001-3

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00415-006-5001-3

Key words

Search

Navigation